Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Piramal Enterprises Ltd announces Q2, H1 FY 2019-20 results

Posted On: 2019-10-22 13:05:01


Piramal Enterprises Limited ('PEL', NSE: PEL, BSE: 500302) has announced its consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2019.

Financial Highlights

Revenue:

- Up 15% at INR 3,604 Crores during Q2 FY2020 vs INR 3,144 Crores in Q2 FY2019
- Up 18% at INR 7,110 Crores during H1 FY2020 Vs INR 6,047 Crores in H1 FY2019

Profit before Tax & Exceptional items

- Up 29% to INR 733 Crores in Q2 FY2020 vs. INR 570 Crores in Q2 FY2019
- Up 25% to INR 1,338 Crores in H1 FY2020 vs. INR 1,073 Crores in H1 FY2019

Net Profit1:

- Up 18% to INR 569 Crores in Q2 FY2020 vs. INR 480 Crores in Q2 FY2019
- Up 19% at INR 1,029 Crores during H1 FY2020 vs INR 863 Crores in H1 FY2019

Note: 1) Net Profit excludes exceptional gain/loss for the period

Mr. Ajay Piramal, Chairman, Piramal Enterprises Ltd. said, "Our diversified business model has enabled us to deliver resilient performance during this quarter, despite continued liquidity tightening in the NBFC sector. The strong fundamentals of the Company are reflected in our H1 and Q2 results:

- H1 FY2020 revenues grew by 18% YoY to INR 7,110 Crores and net profit by 19% YoY to INR 1,029 Crores
- Q2 FY2020 revenues grew by 15% YoY to INR 3,604 Crores and net profit by 18% to INR 569 Crores

Our Financial Services business received inflows of ~INR 45,000 Crores over the past year and brought down CP borrowings by 92% to ~INR 1,480 Crores, reflecting the quality of our underwriting, client selection and risk management practices.

Pharma and Healthcare Insights businesses continue to consistently deliver strong performance quarter on quarter, acting as a natural hedge and bringing stability to the company's performance, even in the most volatile market environment. Our Pharma revenues grew 19% YoY to INR 1,316 Crores in Q2:

- The Global Pharma business delivered strong EBITDA margins of 24%
- India Consumer Products business sustained its strong recovery with YoY revenue growth of 39% in Q2
- Healthcare Insights & Analytics business also grew by 14% to INR 333 Crores, delivering an EBITDA margin of 24% in Q2

We remain committed to bring in additional equity in the company in the near future, which will further bolster our plans to tap both organic and inorganic opportunities across our businesses."

Consolidated Revenues:

Consolidated revenues increased by 15% YoY to INR 3,604 Crores for Q2 FY2020 and 18% YoY to 7,110 Crores for H1 FY 2020. 38% of our revenues were earned in foreign currency for H1 FY2020.

Profit before Tax and Exceptional Items:

Profit before tax and exceptional items increased by 29% YoY to INR 733 Crores for Q2 FY2020 and it increased by 25% YoY to INR 1,338 Crores for H1 FY2020.

Net Profit (excluding exceptional item):

Net Profit (excluding item) increased by 18% YoY to INR 569 Crores for Q2 FY2020 and it increased by 19% YoY to INR 1,029 Crores for H1 FY2020.

Shares of PIRAMAL ENTERPRISES LTD. was last trading in BSE at Rs.1556.35 as compared to the previous close of Rs. 1467.95. The total number of shares traded during the day was 138450 in over 6349 trades.

The stock hit an intraday high of Rs. 1577.3 and intraday low of 1443.25. The net turnover during the day was Rs. 211192445.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Compucom Software Ltd board recommends Final Dividend of Rs. 0.30

Tube Investments of India Ltd standalone Q4 PBT before exceptional items up by 26%

Ujjivan Financial Services Ltd board recommends dividend of Rs. 0.80

Vedanta - VGCB continues to scale-up community outreach activities to combat COVID-19 Pandemic

Aditya Birla Fashion and Retail Ltd Board approves Rs. 100 crore Rights Issue of equity shares

TATA Investment Corporation Ltd Board approves dividend of Rs. 18 for FY2020

Dabur India Ltd Board recommends Final Dividend of Rs. 1.60

First Virtual listing ceremony of Mitsu Chem Plast Ltd. on BSE Mainboard

Heritage Foods Limited Board recommends Dividend of Rs. 2.50 for FY20

D2H launches DIA, an AI-enabled chatbot for customer service

U GRO appoints Global Value Creation Partners to support its development as a premier impact financing platform for MSMEs

IDFC FIRST Bank launches video KYC for online Savings Accounts

Tube Investments of India Limited board skips final dividend

Sun Pharmaceutical Industries Ltd Board approves final dividend of Rs. 1 for FY2020

Aditya Birla Fashion and Retail Limited board approves fund raising of Rs. 1000 crore

DABUR India Ltd posts lower consolidated PAT of Rs. 281.17 crore in Q4 FY20

Sun Pharmaceutical Industries Ltd reports Rs. 399.84 crore consolidated PAT in Q4 FY20

KPIT Technologies Ltd consolidated Q4 net profit at Rs. 37.13 crore

Saksoft Ltd consolidated Q4 FY2020 net profit at Rs. 9.79 crore

JSW Holdings Ltd Q4 consolidated PAT up at Rs. 9.60 crore

Beardsell Ltd board approves 1:3 rights issue

Manappuram Finance Ltd approves issue of NCDs of Rs. 500 crore

TCS iON Readies Exam Centers to Operate with Social Distancing and Hygiene Norms Post Lockdown

TIMKEN India Ltd board to approve quarterly results on June 5, 2020

Relaxo Footwears Ltd board to consider FY20 results, final dividend on June 6, 2020

Tamboli Capital Ltd board to announce FY20 results, dividend on June 13, 2020

Indian Oil Corporation Ltd allots NCDs of Rs. 3000 crore

Sagarsoft (India) Ltd board recommends dividend of Rs. 1.50

Zydus Wellness Ltd board to approve Q4, FY20 results on June 2, 2020

Indostar Capital Finance Ltd allots securities to BCP V Multiple Holdings Pte. Ltd

Aurobindo Pharma Ltd board to consider 4th quarter results on June 3, 2020

Adani Ports and Special Economic Zone Limited raises Rs. 700 crores through NCDs

TCS a Leader and Star Performer in Property & Casualty Insurance BPO Services: Everest Group

Future Retail Ltd board approves raising of upto Rs. 650 crore through NCDs

Garden Reach Shipbuilders & Engineers Ltd board to consider FY20 results, final dividend on June 6, 2020

Birla Cable Ltd board to approve Q4, FY20 results on June 1, 2020

Glenmark Pharmaceuticals receives ANDA approval for Chlorzoxazone Tablets USP, 375 mg and 750 mg

L&T Heavy Engineering Achieves Delivery of Critical Equipment to Global Customers During Lockdown

Wipro positioned as a 'Leader' in Gartner's 2020 Magic Quadrant for Public Cloud Infrastructure Professional and Managed Services, Worldwide

Biocon Biologics Receives DCGI Approval for Emergency Use of CytoSorb® to Treat Critical COVID-19 Patients

Millers Mutual Selects Majesco's Cloud-Native Digital1st® Insurance Platform

Paisalo Digital Ltd board to consider raising funds through NCDs

Blue Dart Express Sales at Rs. 31,664 million

Sun Pharma Advanced Research Company Ltd board to announce 4th quarter results on June 2, 2020

Stovec Industries Ltd board to consider Q4, FY20 results on June 4, 2020

Greaves Cotton Limited board to approve Q4, FY20 results on June 5, 2020

CRISIL reaffirms commercial papers rating of Edelweiss Financial Services Limited

Gulshan Polyols Ltd Q4 PAT at Rs. 2.78 crore

Alkem Laboratories Ltd Board to consider FY20 results & Final Dividend on June 05, 2020

Wonderla Holidays Ltd Q4 FY20 PAT slides to Rs. 1.56 crore







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019